ZYBT Zhengye Biotechnology Holding Limited - Ordinary Shares
NASDAQ · Pharmaceuticals · View on SEC EDGAR ↗ 10-K/10-Q Apr 28, 2026
$1.50
· of 52w range
· above low
· to high
$0.6252w low
$8.0152w high
Market Cap
$71M
EPS
$0.25
Revenue
$116M
your badges
52W Range
$1–$8
Analyst Rating
·
Price Target
·
P/E
·
ROE
-26.2%
Net Profit Margin
-60.0%
Your badge strip is empty — pin a metric anywhere on this page.
ZYBT Stock Snapshot Price, market cap, P/E, EPS, ROE, debt/equity, 52-week range
Price
$1.50
Market Cap
$71M
EPS
$0.25
Revenue
$116M
ROE
-26.2%
Debt/Equity
0.3
52W Range
$1–$8
ZYBT Stock Price Chart Daily OHLCV with technical indicators — pan, zoom, and customize your view
range
bars
Bar granularity adapts to the selected period — hover the chart to see open/high/low/close for a bar.
10-Year Performance Revenue, net income, margins and EPS trends
Revenue$116M2022-12-31 → 2025-12-31
EPS$0.252022-12-31 → 2024-12-31
Free Cash Flow$12M2024-12-31 → 2025-12-31
Net margin-60.0%2024-12-31 → 2025-12-31
Valuation & Ratios
Valuation P/E, P/S, P/B, EV/EBITDA ratios — is the stock expensive or cheap?
| Metric | 5Y trend | ZYBT | 5Y avg | Peer Median | Verdict |
|---|---|---|---|---|---|
| P/S | 0.6 | · | 0.9 | Undervalued | |
| P/B | 0.3 | · | · | · | |
| EV / EBITDA | -1.2 | · | · | · | |
| Price / FCF | 5.8 | · | · | · | |
| Price / Cash Flow | 5.3 | · | · | · | |
| EV / Revenue | 0.7 | · | · | · | |
| EV / FCF | 6.9 | · | · | · | |
| Price / Tangible Book | 0.4 | · | · | · |
Peer median is calculated on a standardized basis per metric and may not always match the TTM/MRQ basis shown for this stock.
Profitability Gross, operating and net margins; ROE, ROA, ROIC
| Metric | 5Y trend | ZYBT | 5Y avg | Peer Median | Verdict |
|---|---|---|---|---|---|
| Gross Margin | 20.5% | · | 21.2% | Weak | |
| Operating Margin | -60.6% | · | -46.9% | Weak | |
| EBITDA Margin | -60.6% | · | -45.0% | Weak | |
| Pretax Margin | -61.8% | · | -57.2% | Weak | |
| Net Profit Margin | -60.0% | · | -56.3% | Weak | |
| ROA | -15.0% | · | -11.6% | Weak | |
| ROE | -26.2% | · | -17.7% | Weak | |
| ROIC | -25.8% | · | · | · |
Financial Health Debt, liquidity, solvency — balance sheet strength
| Metric | 5Y trend | ZYBT | 5Y avg | Peer Median | Verdict |
|---|---|---|---|---|---|
| Debt / Equity | 0.3 | · | · | · | |
| Current Ratio | 1.1 | · | 2.7 | Low liquidity | |
| Quick Ratio | 0.6 | · | 2.1 | Low liquidity |
Growth Revenue, EPS and net income growth: YoY, 3Y CAGR, 5Y CAGR
No data for this ratio group yet
Not enough fundamentals data to compute this ratio group yet.
Capital Efficiency Asset turnover, inventory turnover, receivables turnover
| Metric | 5Y trend | ZYBT | 5Y avg | Peer Median | Verdict |
|---|---|---|---|---|---|
| Asset Turnover | 0.3 | · | 0.2 | Top tier | |
| Inventory Turnover | 1.9 | · | 2.2 | Weak | |
| Receivables Turnover | 3.0 | · | 2.2 | Top tier | |
| Revenue / Employee | ≈$432.6K | · | · | · |
value · ≈ 5Y avg · industry median · verdict relative to median
Full Fundamentals All metrics by year — income statement, balance sheet, cash flow
Income Statement
| Metric | Trend | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Revenue | $116M | $186M | $212M | $260M | |
| Cost of Revenue | $92M | $95M | $94M | $112M | |
| Gross Profit | $24M | $91M | $118M | $148M | |
| R&D Expense | $18M | $13M | $12M | $13M | |
| SG&A Expense | $31M | $23M | $24M | $24M | |
| Operating Expenses | $94M | $75M | $73M | $82M | |
| Operating Income | $-71M | $16M | $45M | $66M | |
| Interest Income | $96.0K | $231.0K | $312.0K | $114.0K | |
| Other Non-op | $-130.0K | $146.0K | $234.0K | $-2M | |
| Pretax Income | $-72M | $14M | $44M | $64M | |
| Income Tax | $11M | $924.0K | $6M | $8M | |
| Net Income | $-70M | $11M | $31M | $47M | |
| EPS (Basic) | · | $0.25 | $0.69 | $1.02 | |
| EPS (Diluted) | · | $0.25 | $0.69 | $1.02 | |
| Shares (Basic) | 47,349,869 | 45,666,376 | 45,666,376 | 45,666,376 | |
| Shares (Diluted) | 47,349,869 | 45,666,376 | 45,666,376 | 45,666,376 | |
| EBITDA | $-71M | $16M | · | · |
Balance Sheet
| Metric | Trend | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Cash & Equivalents | $50M | $19M | $15M | · | |
| Short-term Investments | $2M | $1M | $1M | · | |
| Receivables | $18M | $60M | $74M | · | |
| Inventory | $39M | $58M | $58M | · | |
| Prepaid Expense | $26M | $3M | · | · | |
| Current Assets | $137M | $178M | $189M | · | |
| PP&E (Net) | $237M | $255M | $263M | · | |
| PP&E (Gross) | $368M | $357M | $348M | · | |
| Accum. Depreciation | $132M | $112M | $93M | · | |
| Intangibles | $47M | $15M | $16M | · | |
| Total Assets | $436M | $493M | $500M | · | |
| Accounts Payable | $44M | $43M | $46M | · | |
| Short-term Debt | $65M | $74M | $80M | · | |
| Current Liabilities | $120M | $136M | $150M | · | |
| Capital Leases | $327.0K | · | · | · | |
| Deferred Tax | $104.0K | · | · | · | |
| Total Liabilities | $130M | $141M | $161M | · | |
| Long-term Debt | $10M | $12M | · | · | |
| Total Debt | $66M | $86M | · | · | |
| Common Stock | · | $8.0K | $8.0K | · | |
| Retained Earnings | $-22M | $48M | $38M | · | |
| AOCI | $-2M | $3.0K | · | · | |
| Stockholders' Equity | $250M | $284M | $273M | · | |
| Liabilities + Equity | $436M | $493M | $500M | · | |
| Shares Outstanding | 47,391,376 | 45,666,376 | 45,666,376 | 45,666,376 |
Cash Flow
| Metric | Trend | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| D&A | $26M | $24M | $24M | $19M | |
| Deferred Tax | $11M | $924.0K | $541.0K | $-1M | |
| Amort. of Intangibles | $4M | $3M | $3M | $3M | |
| Operating Cash Flow | $13M | $41M | $48M | $17M | |
| CapEx | $1M | $14M | $7M | $27M | |
| Investing Cash Flow | $-13M | $-28M | $-12M | $-27M | |
| Dividends Paid | · | $16M | $39M | $21M | |
| Financing Cash Flow | $32M | $-22M | $-19M | $13M | |
| Net Change in Cash | $32M | $-9M | $17M | · | |
| Taxes Paid | · | $116.0K | $10M | $8M | |
| Free Cash Flow | $12M | $27M | · | · |
Profitability
| Metric | Trend | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Gross Margin | 20.5% | 49.0% | · | · | |
| Operating Margin | -60.6% | 8.8% | · | · | |
| Net Margin | -60.0% | 6.1% | · | · | |
| Pretax Margin | -61.8% | 7.7% | · | · | |
| EBITDA Margin | -60.6% | 8.8% | · | · | |
| ROA | -15.0% | 2.3% | · | · | |
| ROE | -26.2% | 4.1% | · | · | |
| ROIC | -25.8% | 4.2% | · | · |
Liquidity & Solvency
| Metric | Trend | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Current Ratio | 1.1 | 1.3 | · | · | |
| Quick Ratio | 0.6 | 0.6 | · | · | |
| Debt / Equity | 0.3 | 0.3 | · | · | |
| LT Debt / Equity | · | 0.0 | · | · |
Efficiency
| Metric | Trend | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Asset Turnover | 0.3 | 0.4 | · | · | |
| Inventory Turnover | 1.9 | 1.6 | · | · | |
| Receivables Turnover | 3.0 | 2.8 | · | · |
Per Share
| Metric | Trend | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Book Value / Share | $5.27 | $6.22 | · | · | |
| Revenue / Share | $2.46 | $4.08 | · | · | |
| Cash Flow / Share | $0.28 | $0.90 | · | · | |
| Cash / Share | $1.06 | $0.41 | · | · | |
| EPS (TTM) | · | $0.25 | · | · |
Valuation (TTM)
| Metric | Trend | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Revenue TTM | $116M | $186M | · | · | |
| Net Income TTM | $-70M | $11M | · | · | |
| Market Cap | $55M | · | · | · | |
| Enterprise Value | $68M | · | · | · | |
| P/S | 0.5 | · | · | · | |
| P/B | 0.2 | · | · | · | |
| P / Tangible Book | 0.3 | · | · | · | |
| P / Cash Flow | 4.1 | · | · | · | |
| P / FCF | 4.4 | · | · | · | |
| EV / EBITDA | -1.0 | · | · | · | |
| EV / FCF | 5.6 | · | · | · | |
| EV / Revenue | 0.6 | · | · | · | |
| Payout Ratio | · | 141.7% | · | · | |
| Annual Payout | · | $16M | · | · |
No quarterly filings for ZYBT
We don't have SEC filings for this ticker yet.
Most recent period on the left · null values shown as ·
Financial Statements Income statement, balance sheet, cash flow — annual, last 5 years
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Revenue | $116M | $186M | $212M | $260M |
| Gross Margin % | 20.5% | 49.0% | · | · |
| Operating Margin % | -60.6% | 8.8% | · | · |
| Net Income | $-70M | $11M | $31M | $47M |
| Diluted EPS | · | $0.25 | $0.69 | $1.02 |
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Debt / Equity | 0.3 | 0.3 | · | · |
| Current Ratio | 1.1 | 1.3 | · | · |
| Quick Ratio | 0.6 | 0.6 | · | · |
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Free Cash Flow | $12M | $27M | · | · |
Institutional owners (13F) 8 filers · $68K total · As of June 30, 2026
Institutions that report holding this stock in their quarterly SEC Form 13F. Long positions only; a single filer may appear twice for separate option legs. Large offsetting put/call legs typically reflect market-making or hedged inventory, not directional conviction.
Holders
8
Value held
$68K
New positions
1
Exited positions
1
Institutional activity — Q2 2026 vs prior quarter
| New positions | Exited positions | Increased | Decreased | Net shares change |
|---|---|---|---|---|
| 1 (+1 vs prior Q) | 1 (-1 vs prior Q) | 1 (-1 vs prior Q) | 3 (-1 vs prior Q) | -21K |
Compared to Q1 2026. SEC Form 13F filings are due within 45 days of quarter-end plus a short buffer for late filers — quarters still inside that window are skipped in favor of the most recent fully-reported pair.
| Institution | Value | Shares | % of tracked 13F | Type |
|---|---|---|---|---|
| XTX Topco Ltd | $33,086 | 48,865 | 48.61% | Shares |
| GEODE CAPITAL MANAGEMENT, LLC | $19,681 | 29,068 | 28.92% | Shares |
| WINTON GROUP Ltd | $8,619 | 12,730 | 12.66% | Shares |
| UBS Group AG | $5,410 | 7,992 | 7.95% | Shares |
| ROYAL BANK OF CANADA | $1,000 | 1,230 | 1.47% | Shares |
| MORGAN STANLEY | $168 | 248 | 0.25% | Shares |
| JPMORGAN CHASE & CO | $93 | 134 | 0.14% | Shares |
| Caitong International Asset Management Co., Ltd | $1 | 1 | 0.00% | Shares |
Peer comparison (GICS sub-industry) Key metrics vs sector peers
FY basis, prices as of each company's last fiscal year-end close.
My Metrics Your personal watchlist — selected rows from Full Fundamentals
Pick the metrics that matter to you — click the + next to any row in Full Fundamentals above.
Your selection is saved and follows you across all tickers.
Source: SEC 20-F filed Apr 28, 2026